Jean-Yves Nothias

Societé Générale Asset Management Alternative Investment/Private Equity (SGAM AI/PE) is the banking group's European asset management center for Private Equity. They are located in Paris-La Défense. SGAM AI/PE is a division of the Société Générale Asset Management, established in 2003, which is a subsidiary of the bank's Global Investment Management and Services division. The ultimate parent firm is the French financial institution Société Générale (PK: SCGLY), established in 1864. Nationalized at different intervals throughout their history, the bank is in the private sector since 1997. SGAM AI/PE is composed of three units: venture capital, expansion capital and buyout, and fund of funds. In addition to their Paris office, they are also present in London, Milan, Munich, Warsaw, Bucharest and Casablanca.

Gene-IT, Inc. (GenomeQuest, Inc.) provides software solutions to life-science research organizations. It makes sequence information available to all end-users in life sciences. The firm identifies new applications and adapts sequence search technology to serve life science end-users. The company was founded by Dr. Jean-Jacques Codani and Eric Glémet in 1998 and is located in Westborough, MA.

GQ Life Sciences, Inc. provides software solutions to life science research organizations. It offers LifeQuest, a patent search platform specific for the life sciences that provides a solution for semantic keyword and life science ontology searching; and GenomeQuest that integrates full-text search and sequence search in the intellectual property domain. The company was founded by Eric Glemet in 1998 and is headquartered in Boston, MA.

Amundi Private Equity Funds SA (Amundi PEF) is the private equity subsidiary of Amundi SA, itself a subsidiary of Crédit Agricole SA (XP: ACA) in France. Formerly known as CAAM-CI, founded in 1999 as CPR Private Equity, Amundi PEF was formed in 2009 by combining the Crédit Agricole and Société Générale asset management operations. The firm is headquartered in Paris and has additional offices in Bucharest, Cairo, Casablanca, Tunis and Warsaw. They invest in companies at all stages of development, providing institutional and individual investors with a wide spectrum of investment opportunities.

Vesalius Biocapital Partners SARL (Vesalius Biocapital Partners) is an independent venture capital firm founded in 2007 by Stéphane Verdood. The firm is headquartered in Luxembourg.